Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pulmatrix (PULM)
NASDAQ:PULM
Holding PULM?
Track your performance easily
PULM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.55 - $8.44
Previous CloseN/A
Volume31.27K
Average Volume (3M)84.05K
Market Cap
$21.55M
Enterprise Value-$2.97M
Total Cash (Recent Filing)$4.18M
Total Debt (Recent Filing)$3.22M
Price to Earnings (P/E)―
Beta-1.21
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.64
Shares Outstanding3,652,285
10 Day Avg. Volume54,956
30 Day Avg. Volume84,051
Standard Deviation0.32
R-Squared0.06
Alpha-0.00098
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.19
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.14
Enterprise Value/Revenue-0.30
Enterprise Value/Gross Profit-0.41
Enterprise Value/Ebitda0.31
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pulmatrix News
PremiumCompany Announcements
Pulmatrix and Cullgen Announce Strategic Merger Agreement
PremiumCompany Announcements
Pulmatrix Announces Executive Changes and New Interim CEOOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.94% Mutual Funds
<0.01% Other Institutional Investors
97.03% Public Companies and
Individual Investors
PULM FAQ
What was Pulmatrix’s price range in the past 12 months?
Pulmatrix lowest stock price was $1.55 and its highest was $8.44 in the past 12 months.
What is Pulmatrix’s market cap?
Pulmatrix’s market cap is $21.55M.
When is Pulmatrix’s upcoming earnings report date?
Pulmatrix’s upcoming earnings report date is Mar 27, 2025 which is in 71 days.
How were Pulmatrix’s earnings last quarter?
Pulmatrix released its earnings results on Nov 08, 2024. The company reported -$0.71 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.71.
Is Pulmatrix overvalued?
According to Wall Street analysts Pulmatrix’s price is currently Overvalued.
Does Pulmatrix pay dividends?
Pulmatrix does not currently pay dividends.
What is Pulmatrix’s EPS estimate?
Pulmatrix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pulmatrix have?
Pulmatrix has 3,652,285 shares outstanding.
What happened to Pulmatrix’s price movement after its last earnings report?
Pulmatrix reported an EPS of -$0.71 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.442%.
Which hedge fund is a major shareholder of Pulmatrix?
Currently, no hedge funds are holding shares in PULM
---
Company Description
Pulmatrix
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer, Jr. on June 15, 2015 and is headquartered in Lexington, MA.
---
Technical Analysis
Medicinova
―
Oragenics
―
TG Therapeutics
―
Actinium Pharmaceuticals
―
Syndax Pharmaceuticals
―
Tonix Pharma
―
---